Remeron Rd 45 mg (Mirtazapine TABLET (ORALLY DISINTEGRATING)) 45 MG

Remeron RD 45 mg is an orally disintegrating tablet containing mirtazapine, used for managing depression and anxiety. This medication works by balancing certain natural substances in the brain.

Strength

45 MG

Manufacturer / TM Owner

ORGANON CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Remeron RD 45 mg is primarily used for the treatment of major depressive disorder and anxiety. It may also be prescribed for other mood-related conditions. The active ingredient, mirtazapine, helps to restore the balance of neurotransmitters in the brain, which can improve mood and reduce symptoms of depression and anxiety.

Side Effects

Common effects of Remeron RD 45 mg may include drowsiness, increased appetite, and weight gain. Some users may also experience dizziness or dry mouth. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Remeron RD 45 mg should be used with caution in individuals with a history of seizures, liver disease, or bipolar disorder. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Keep the tablets in a cool, dry place and away from children.

Avoid Interactions

Remeron RD 45 mg may interact with other medications, including those that cause drowsiness, such as alcohol and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before combining Remeron RD with other treatments.

Frequently Asked Questions

Remeron RD 45 mg is used to treat major depressive disorder and anxiety by balancing neurotransmitters in the brain.

Remeron RD 45 mg is an orally disintegrating tablet that should be placed on the tongue and allowed to dissolve without water.

Common side effects may include drowsiness, increased appetite, weight gain, dizziness, and dry mouth.

It is generally advised to avoid alcohol while taking Remeron RD 45 mg, as it can increase drowsiness and other side effects.

Remeron RD 45 mg should be used with caution in individuals with certain medical conditions, such as seizures or liver disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.